Xenon Pharmaceuticals (XENE) has released an update.
Xenon Pharmaceuticals Inc., a company specializing in neurological and psychiatric treatments, is set to present at the prestigious Leerink Partners Global Biopharma Conference in Miami from March 11-13, 2024. Investors and interested parties can tune into a live webcast of the presentation by the company’s President, Ian Mortimer, and CFO, Sherry Aulin. The event promises insights into Xenon’s latest advancements in therapeutics for conditions such as epilepsy and depression.
For further insights into XENE stock, check out TipRanks’ Stock Analysis page.
